In the Media: highlights from Microbiology and Immunology August 2021

Our experts from the Dept of Microbiology & Immunology at the Peter Doherty Institute have been at the forefront of COVID-19 breakthrough research and media commentary. Catch up on the latest highlights here.

  • Ben Howden and Michelle Sait spoke to Fairfax about LabVan, a van commissioned by the Peter Doherty Institute to be deployed for quick turnaround COVID-19 testing.
  • Christopher McDevitt and Bio21 collaborator Megan Maher released research that showed how starving pneumonia-causing bacteria of their favourite food could lead to new antibiotics. An article appeared in Pursuit.
  • Deborah Williamson co-wrote a piece for The Conversation on rapid antigen tests.
  • Kanta Subbarao featured in an article for Nature about the potential for updates of the COVID-19 vaccines.
  • NewsGP spoke to Dale Godfrey about the latest data on mixing COVID-19 vaccines.
  • Peter Doherty
    • Peter spoke to Channel 10 about the current COVID-19 situation in Australia, to Fairfax about whether herd immunity against COVID-19 is achievable and to News Corp about how the people who will die of COVID-19 will be the unvaccinated. He also spoke with 5AA Adelaide about why the Delta variant seems to be infecting more children than previous strains.
    • He spoke to the Warrnambool Standard, Radio National, News Corp and ABC News, providing information on COVID-19 vaccines and their impact on the pandemic. Peter also spoke to News Corp about COVID-19 vaccine immunity and whether increasing coverage in NSW will help in current outbreak.
    • He was a guest on 730 and spoke with ABC Radio National , The Herald Sun and 3AW, reflecting on his experience during the past 18 months of the COVID-19 pandemic and promoting his book, An Insider's Plague Year. The Age ran a feature on his new book.
  • The Kirby Institute distributed a media release regarding a $5 million grant that will allow international collaborators (including researchers from the Dept of Microbiology and Immunology) to strengthen lab testing and diagnosis of infectious diseases such as COVID-19.

You can find out more about our research projects and groups in the Department of Microbiology and Immunology here.

Read more